FDA Clears Toshiba’s Latest Dose Reduction Software
Adaptive Iterative Dose Reduction (ADIR) 3D, the third generation software, will be offered to existing Aquilion One, Premium, and Prime CT customers.
Toshiba America Medical Systems Inc.’s latest dose reduction software, Adaptive Iterative Dose Reduction (ADIR) 3D, has received FDA clearance, the company announced.
The third generation software, which Toshiba will offer to existing Aquilion One, Premium, and Prime CT customers, reduces radiation dose compared to conventional scanning, the company said. The algorithm, designed to work in raw data and imaging data space, reduces noise while attempting to maintain image quality.
The ADIR 3D can be integrated with Sure Exposure 3D, software that calculates the minimum radiation exposure required for every exam based on pre-set targeted level of image quality.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
